Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of Manitoba
$27,000.00
Strategies to Preserve Immunoprivilege in Allogeneic Mesenchymal Stem Cells for Cardiac Repair
EF 2025-26
Résumé
Ischemic heart disease (IHD) remains the leading cause of global mortality. Current therapies fail to regenerate damaged myocardium, necessitating novel strategies. Allogenic mesenchymal stem cells (allo-MSCs) offer a promising therapeutic avenue due to their regenerative potential, paracrine signaling and inherent immunoprivilege properties, which enables survival in host without any immune rejection. However, preclinical efficacy has been modest efficacy, primarily due to the loss of immunoprivilege upon transplantation to the ischemic heart.
This project aims to identify the upstream regulators responsible for hypoxia-induced (HI) degradation of cyclooxygenase-2 (COX-2), the rate limiting enzyme in prostaglandin E2 (PGE2) synthesis essential for preserving immunoprivilege. We will employ integrated multiomic profiling to determine HI factors, alongside co-immunoprecipitation and loss of function studies to map molecular interactions between COX-2 and immunoproteasomal components.
Significantly, this proposal integrates a sex and gender dimension by integrating a unique hormonal dimension in the contract of the transgender community. We will examine the effects of estrogen and testosterone mimicking gender-affirming hormone therapy (GAHT) on COX-2 stability, and PGE2 production under hypoxia.
We will elucidate cellular signaling mechanisms involving estrogen receptor B, androgen receptor, and HIF-1A to determine how sex hormones modulate immunoproteasomal activity and COX-2 degradation. By bridging regenerative biology, immunology, and endocrinology, this study advances inclusive cardiac regenerative medicine. Ultimately, informing sex-specific and gender-responsive strategies in cardiac repair, ensuring future regenerative therapies are effective and equitable.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Manitoba, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
572698
Name
Jamila Joshua Inrixie Santos
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Strategies to Preserve Immunoprivilege in Allogeneic Mesenchymal Stem Cells for Cardiac Repair
Programtype2
Studentship Programs
Orgnameinp2
University of Manitoba
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Allogenic Mesenchymal Stem Cells; Cardiac Regeneration; Cyclooxygenase-2; Gender Affirming Hormone Therapy; Hypoxia; Immunoprivilege; Ischemic Heart Disease; Prostaglandin E2; Sex And Gender; Sex Hormones
Abstract
Ischemic heart disease (IHD) remains the leading cause of global mortality. Current therapies fail to regenerate damaged myocardium, necessitating novel strategies. Allogenic mesenchymal stem cells (allo-MSCs) offer a promising therapeutic avenue due to their regenerative potential, paracrine signaling and inherent immunoprivilege properties, which enables survival in host without any immune rejection. However, preclinical efficacy has been modest efficacy, primarily due to the loss of immunoprivilege upon transplantation to the ischemic heart.
This project aims to identify the upstream regulators responsible for hypoxia-induced (HI) degradation of cyclooxygenase-2 (COX-2), the rate limiting enzyme in prostaglandin E2 (PGE2) synthesis essential for preserving immunoprivilege. We will employ integrated multiomic profiling to determine HI factors, alongside co-immunoprecipitation and loss of function studies to map molecular interactions between COX-2 and immunoproteasomal components.
Significantly, this proposal integrates a sex and gender dimension by integrating a unique hormonal dimension in the contract of the transgender community. We will examine the effects of estrogen and testosterone mimicking gender-affirming hormone therapy (GAHT) on COX-2 stability, and PGE2 production under hypoxia.
We will elucidate cellular signaling mechanisms involving estrogen receptor B, androgen receptor, and HIF-1A to determine how sex hormones modulate immunoproteasomal activity and COX-2 degradation. By bridging regenerative biology, immunology, and endocrinology, this study advances inclusive cardiac regenerative medicine. Ultimately, informing sex-specific and gender-responsive strategies in cardiac repair, ensuring future regenerative therapies are effective and equitable.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Jamila, Joshua Inrixie Santos
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~